Company profilePharmaceutical#108 of 1,318 in Pakistan2 DRAP alerts

RAKAPOSHI PHARMACEUTICAL (PVT) LTD.

Pharmaceutical company · 148 brands · 151 molecules

Ranked #28 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

148 registered products 41 pharmaceutical brands 151 distinct molecules 2 DRAP alerts

Company overview

148
registered products
41
pharmaceutical brands
151
distinct molecules
12
therapeutic classes
2
DRAP alerts

RAKAPOSHI PHARMACEUTICAL (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 148 product registrations across 151 distinct molecules. It is the 108th largest registrant in Pakistan by product count, and ranks 28th of 311 in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Vitamin B Complex Plain & With Vitamin C. DRAP has issued 2 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by RAKAPOSHI

46 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 3
Antithrombotic Agents 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

46
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202646

Top molecules by brand count

Azithromycin4 brands
Cefixime4 brands
Omeprazole4 brands
Risperidone4 brands
Ceftriaxone4 brands
Doxycycline3 brands
Folic Acid3 brands
Erythromycin3 brands
Propranolol3 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 7Vitamin B Complex Plain & With Vitamin C · 2Antianemic, Iron Preparations · 1Vitamin A, D & Combinations · 1Antianemic, Iron & All Combination · 1Antispasmodic & Anticholinergic · 1Vitamin B12 Plain · 1Antiemetics & Antinauseants · 1Macrolides, Lincosamides And Streptogramins · 1Lipid Modifying Agents · 1Antivirals For Systemic Use · 1Drugs For Urinary Frequency And Incontinence · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official87 products · Rs 45.51 – Rs 3,956.92
Median across source: Rs 332.84

Regulatory record

2 alerts in the DRAP feed we track.

Series of Training on National Pharmacovigilance System for Registration holders (Manufact
2024-06-12
Consultative Workshop on Guidelines on Recalls and Rapid Alerts of Defective Therapeutic G
2023-07-21

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 113 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
BIO LABS (PVT) LTD. holds 118 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtesunateAscorbic Acid
NABIQASIM INDUSTRIES (PVT) LTD. holds 174 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir

Get the full profile for RAKAPOSHI

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.